CN103055191B - 一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 - Google Patents
一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 Download PDFInfo
- Publication number
- CN103055191B CN103055191B CN201310056446.1A CN201310056446A CN103055191B CN 103055191 B CN103055191 B CN 103055191B CN 201310056446 A CN201310056446 A CN 201310056446A CN 103055191 B CN103055191 B CN 103055191B
- Authority
- CN
- China
- Prior art keywords
- golden cypress
- preparation
- chinese medicine
- traditional chinese
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 53
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 201000008383 nephritis Diseases 0.000 title abstract description 5
- 238000001514 detection method Methods 0.000 title abstract 3
- 241000218691 Cupressaceae Species 0.000 claims abstract description 60
- 239000000463 material Substances 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 14
- 238000007796 conventional method Methods 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000006187 pill Substances 0.000 claims abstract description 4
- 210000002700 urine Anatomy 0.000 claims description 31
- 210000004369 blood Anatomy 0.000 claims description 30
- 239000008280 blood Substances 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 14
- 210000003734 kidney Anatomy 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 240000001579 Cirsium arvense Species 0.000 claims description 9
- 235000005918 Cirsium arvense Nutrition 0.000 claims description 9
- 244000269722 Thea sinensis Species 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- 235000019640 taste Nutrition 0.000 claims description 5
- -1 and filter Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 240000007171 Imperata cylindrica Species 0.000 claims 2
- 238000012360 testing method Methods 0.000 abstract description 29
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 abstract description 14
- 241001598107 Imperata Species 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 12
- 238000000605 extraction Methods 0.000 abstract description 7
- 239000002245 particle Substances 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 238000013461 design Methods 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000717673 Clerodendranthus spicatus Species 0.000 abstract 1
- 238000004809 thin layer chromatography Methods 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 40
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 238000000034 method Methods 0.000 description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 16
- 239000000470 constituent Substances 0.000 description 14
- 239000000523 sample Substances 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000013558 reference substance Substances 0.000 description 6
- 239000004375 Dextrin Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000008236 heating water Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 229940126534 drug product Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 235000008738 Clausena lansium Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037597 Pyelonephritis acute Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 244000299492 Thespesia populnea Species 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000001555 acute pyelonephritis Diseases 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000001572 anti-trichomonad Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- REFMEZARFCPESH-UHFFFAOYSA-M sodium;heptane-1-sulfonate Chemical compound [Na+].CCCCCCCS([O-])(=O)=O REFMEZARFCPESH-UHFFFAOYSA-M 0.000 description 1
- DNGFNWGTMRTCAW-UHFFFAOYSA-M sodium;heptane-1-sulfonate;phosphoric acid Chemical compound [Na+].OP(O)([O-])=O.CCCCCCCS(O)(=O)=O DNGFNWGTMRTCAW-UHFFFAOYSA-M 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
序号 | 参 数 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 |
1 | 肾茶 | 250克 | 200克 | 225克 | 300克 | 275克 |
2 | 小蓟 | 650克 | 600克 | 700克 | 550克 | 500克 |
3 | 白茅根 | 90克 | 120克 | 80克 | 110克 | 100克 |
4 | 黄柏 | 200克 | 180克 | 150克 | 225克 | 250克 |
5 | 黄柏浸泡加温 | 58℃ | 55℃ | 60℃ | 63℃ | 65℃ |
6 | 黄柏浸泡保温 | 40小时 | 44小时 | 42小时 | 48小时 | 45小时 |
7 | 黄柏提取温度 | 80℃ | 82℃ | 84℃ | 81℃ | 85℃ |
8 | 糊精 | 107.1克 | 104.5克 | 115.5克 | 94.8克 | 95.6克 |
9 | 甜菊素 | 25克 | 15克 | 20克 | 23克 | 17克 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310056446.1A CN103055191B (zh) | 2013-02-22 | 2013-02-22 | 一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310056446.1A CN103055191B (zh) | 2013-02-22 | 2013-02-22 | 一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103055191A CN103055191A (zh) | 2013-04-24 |
CN103055191B true CN103055191B (zh) | 2015-07-01 |
Family
ID=48098285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310056446.1A Active CN103055191B (zh) | 2013-02-22 | 2013-02-22 | 一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103055191B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105467059B (zh) * | 2015-12-30 | 2017-10-24 | 云南理想药业有限公司 | 一种治疗血尿的中药组合物的质量检测方法 |
CN110376317A (zh) * | 2018-04-13 | 2019-10-25 | 广州万正药业有限公司 | 一种黄柏对照提取物及其制备方法和应用 |
CN110927320B (zh) * | 2019-02-25 | 2022-03-04 | 广州白云山医药集团股份有限公司白云山何济公制药厂 | 田七跌打风湿软膏的鉴别方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562225A (zh) * | 2004-04-16 | 2005-01-12 | 云南理想药业有限公司 | 一种治疗多种肾脏疾病所致血尿的药物及其制备方法 |
CN1261154C (zh) * | 2004-09-15 | 2006-06-28 | 张平 | 一种用于治疗泌尿系统感染的中药胶囊剂及其制备方法 |
CN101288753B (zh) * | 2007-04-20 | 2011-02-09 | 北京亚东生物制药有限公司 | 一种治疗血尿的中药组合物及其制备方法和检测方法 |
CN101259260A (zh) * | 2008-04-17 | 2008-09-10 | 陕西康惠制药有限公司 | 一种治疗慢性萎缩性胃炎的中药的质量检测方法 |
-
2013
- 2013-02-22 CN CN201310056446.1A patent/CN103055191B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103055191A (zh) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101422563B (zh) | 治疗小儿咽喉炎的中药组合物及其制备方法和质量检测方法 | |
CN1768854B (zh) | 一种用于溃疡性结肠炎的中药胶囊制剂 | |
CN1954868B (zh) | 治疗虚火上炎所致疾病的银菊清咽制剂的检测方法 | |
CN101274025A (zh) | 一种具有清热泻火解毒作用的中药组合物及其制备方法和质量控制方法 | |
CN1876039B (zh) | 治疗上呼吸道感染等疾病的药物制剂的检测方法 | |
CN101856449A (zh) | 一种清热利湿,活血通淋中药组合物及制备方法和质量检测方法 | |
CN102119992B (zh) | 一种鲜品益母草和鲜品芦荟的药用制剂及其制备方法 | |
CN103230517B (zh) | 一种沙参麦冬汤配方颗粒及其制备方法和检测方法 | |
CN1958003B (zh) | 治疗慢性鼻炎及鼻窦炎的制剂及其制法和检测方法 | |
CN102397342B (zh) | 一种金荞麦提取物,含其制剂及其制备方法 | |
CN103055191B (zh) | 一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 | |
CN101843667B (zh) | 一种双黄连药物组合物及其制备方法 | |
CN101843884B (zh) | 用于治疗手足口病的抗病毒口服液的质量检测方法 | |
CN101011566B (zh) | 一种治疗慢性盆腔炎的药物组合物及制备方法和质量控制方法 | |
CN102151322A (zh) | 一种治疗小儿感冒的中药组合物及制法和检测方法 | |
CN101890087A (zh) | 含有黄连、大黄、黄芩的组合物 | |
CN1981852A (zh) | 一种天麻醒脑制剂及其制法和质控方法 | |
CN100574792C (zh) | 一种中药组合物的有效成分检测方法 | |
CN102058637B (zh) | 一种黄花败酱浸膏的制备方法 | |
CN101057895B (zh) | 治疗妇科疾病的妇炎舒制剂及其质量检测方法 | |
CN103893361A (zh) | 一种治疗糖尿病的药物组合物及其应用 | |
CN102697932B (zh) | 治疗皮肤瘙痒的药物组合物及质量检测方法 | |
CN104524041A (zh) | 一种灯心止血胶囊及其制备与鉴别方法 | |
CN101574387B (zh) | 垂盆草制剂的检测方法 | |
CN100542595C (zh) | 一种中药组合物及其制备方法和分析方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 650503 Kunming new town high tech industrial base, Hing Street, No. 39, Yunnan Patentee after: YUNNAN LEIYUNSHANG LIXIANG PHARMACEUTICAL CO.,LTD. Address before: 650000 Kunming national high tech Development Zone, Yunnan Province, Jin Road, No. 139 Patentee before: YUNNAN LIXIANG PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 39 Huanxing Street, High tech Industrial Base, Kunming New City, Yunnan Province, 650503 Patentee after: Yunnan Leiyunshang Pharmaceutical Co.,Ltd. Country or region after: China Address before: No. 39 Huanxing Street, High tech Industrial Base, Kunming New City, Yunnan Province, 650503 Patentee before: YUNNAN LEIYUNSHANG LIXIANG PHARMACEUTICAL CO.,LTD. Country or region before: China |
|
CP03 | Change of name, title or address |